DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Patent 6,846,413 protects SPIRIVA RESPIMAT and STIOLTO RESPIMAT and is included in two NDAs.
Protection for SPIRIVA RESPIMAT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-one patent family members in thirty-seven countries.
Summary for Patent: 6,846,413
|Abstract:||A microstructured filter for a fluid, the filter having an inlet for unfiltered fluid and an outlet for filtered fluid, the filter comprising: a plurality of projections (7) which are arranged in at least two rows (3) in mutually juxtaposed relationship and which project out of a base plate (1) and which are an integral component of the base plate, a plurality of passages (8) between the projections (7), and a cover plate which is securable to the base plate to cover the projections (7) and the passages (8), wherein the passages form a plurality of through paths from the inlet to the outlet, said inlet comprises an elongate inlet slot (5) for the unfiltered fluid, which extends over approximately the entire filter width and which is approximately as high as the projection (7) projecting out of the base plate, on the outlet side of the filter. The filter according to the invention remains operational, even if a part of the filter area is obstructed. The filter is used for example in an atomizer with which an aerosol is produced from a fluid which contains a medicament.|
|Inventor(s):||Kadel; Klaus (Willen, DE), Geser; Johannes (Dortmund, DE), Eicher; Joachin (Dortmund, DE), Freund; Bernhard (Gau-Algesheim, DE), Dunne; Stephen Terence (Woodbridge, DE), Bachtler; Wulf (Mainz, DE)|
|Assignee:||Boehringer Ingelheim International GmbH (DE)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use||Submissiondate|
|Boehringer Ingelheim||SPIRIVA RESPIMAT||tiotropium bromide||SPRAY, METERED;INHALATION||021936-002||Sep 15, 2015||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|Boehringer Ingelheim||SPIRIVA RESPIMAT||tiotropium bromide||SPRAY, METERED;INHALATION||021936-001||Sep 24, 2014||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Boehringer Ingelheim||STIOLTO RESPIMAT||olodaterol hydrochloride; tiotropium bromide||SPRAY, METERED;INHALATION||206756-001||May 21, 2015||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Patented / Exclusive Use||>Submissiondate|
Foreign Priority and PCT Information for Patent: 6,846,413
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|